{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:34:11Z","timestamp":1792784051049,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["104-S2646"],"award-info":[{"award-number":["104-S2646"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["UN103-065"],"award-info":[{"award-number":["UN103-065"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"NSC","doi-asserted-by":"publisher","award":["102-2314-B-002-078-MY3"],"award-info":[{"award-number":["102-2314-B-002-078-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MOST","award":["103-2220-E-002-011"],"award-info":[{"award-number":["103-2220-E-002-011"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.07.293","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T08:18:27Z","timestamp":1470212307000},"page":"895-900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-1441","authenticated-orcid":false,"given":"Yen-Hung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Fan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Shen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yu Daisy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lwun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcard.2016.07.293_bb0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/CIRCHEARTFAILURE.112.000146","article-title":"Galectin-3 and cardiac function in survivors of acute myocardial infarction","volume":"6","author":"Weir","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2016.07.293_bb0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/CIRCHEARTFAILURE.113.000403","article-title":"Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study","volume":"6","author":"Eschalier","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2016.07.293_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.CIR.89.1.68","article-title":"Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril","volume":"89","author":"St John Sutton","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2016.07.293_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1748-1716.2008.01881.x","article-title":"Extracellular matrix profiles in the progression to heart failure. European young physiologists symposium keynote lecture-bratislava","volume":"194","author":"Graham","year":"2007","journal-title":"Acta Physiol (Oxford) 2008"},{"issue":"4","key":"10.1016\/j.ijcard.2016.07.293_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.amjcard.2010.03.060","article-title":"Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction","volume":"106","author":"Kelly","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2016.07.293_bb0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2010.04.034","article-title":"The prognostic value of circulating markers of collagen turnover after acute myocardial infarction","volume":"150","author":"Manhenke","year":"2011","journal-title":"Int. J. Cardiol."},{"issue":"17","key":"10.1016\/j.ijcard.2016.07.293_bb0035","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/eurheartj\/ehn315","article-title":"Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction","volume":"29","author":"Kelly","year":"2008","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2016.07.293_bb0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMp020057","article-title":"B-type natriuretic peptide \u2013 a window to the heart","volume":"347","author":"Baughman","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2016.07.293_bb0045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2310\/JIM.0b013e3182946b69","article-title":"Natriuretic peptides as biomarkers in heart failure","volume":"61","author":"Januzzi","year":"2013","journal-title":"J. Investig. Med."},{"issue":"16","key":"10.1016\/j.ijcard.2016.07.293_bb0050","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.jacc.2014.01.014","article-title":"Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction","volume":"63","author":"Seropian","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.07.293_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/jmcc.2001.1484","article-title":"Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction","volume":"34","author":"Scheuren","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"33","key":"10.1016\/j.ijcard.2016.07.293_bb0060","doi-asserted-by":"crossref","first-page":"13,231","DOI":"10.1073\/pnas.1209919109","article-title":"Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan","volume":"109","author":"Cheng","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.ijcard.2016.07.293_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088507","article-title":"Quiescent and proliferative fibroblasts exhibit differential p300 HAT activation through control of 5-methoxytryptophan production","volume":"9","author":"Cheng","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijcard.2016.07.293_bb0070","first-page":"198","article-title":"The serum concentrations of procollagen propeptides in hypertensive patients with or without diabetes","volume":"24","author":"Yu-Chen Wang","year":"2008","journal-title":"Acta Cardiol. Sin."},{"issue":"12","key":"10.1016\/j.ijcard.2016.07.293_bb0075","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"2","key":"10.1016\/j.ijcard.2016.07.293_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2016.07.293_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"issue":"13","key":"10.1016\/j.ijcard.2016.07.293_bb0090","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ijcard.2016.07.293_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cll.2013.11.007","article-title":"Natriuretic peptides in heart failure and acute coronary syndrome","volume":"34","author":"Gaggin","year":"2014","journal-title":"Clin. Lab. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2016.07.293_bb0100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/eurheartj\/ehn007","article-title":"The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study","volume":"29","author":"West","year":"2008","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2016.07.293_bb0105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1536\/ihj.46.1007","article-title":"Relationship between the plasma levels of brain natriuretic peptide and left ventricular ejection fraction in asymptomatic patients with previous myocardial infarction","volume":"46","author":"Watanabe","year":"2005","journal-title":"Int. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2016.07.293_bb0110","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1253\/circj.68.923","article-title":"Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction","volume":"68","author":"Nakagawa","year":"2004","journal-title":"Circ. J."},{"issue":"14","key":"10.1016\/j.ijcard.2016.07.293_bb0115","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jacc.2012.12.044","article-title":"B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction","volume":"61","author":"van Veldhuisen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2016.07.293_bb0120","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejheart.2008.02.015","article-title":"Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality","volume":"10","author":"Frantz","year":"2008","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.ijcard.2016.07.293_bb0125","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.7150\/ijms.8083","article-title":"Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure","volume":"11","author":"Chang","year":"2014","journal-title":"Int. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.ijcard.2016.07.293_bb0130","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1515\/CCLM.2010.348","article-title":"The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death","volume":"48","author":"Lin","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2016.07.293_bb0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cardfail.2004.01.010","article-title":"Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure","volume":"10","author":"Cicoira","year":"2004","journal-title":"J. Card. Fail."},{"issue":"22","key":"10.1016\/j.ijcard.2016.07.293_bb0140","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316316722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316316722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T14:23:53Z","timestamp":1536503033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316316722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"alternative-id":["S0167527316316722"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.293","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}